Results here are the first to show that AQP1 ion channel blocker AqB011 reduces colon cancer cell invasiveness in vitro, and to show that sensitivity to this agent depends on AQP1 localization in the plasma membrane. This evidence concerns the gene AQP1 and colonic neoplasm.